# EDGAR Filing Document

**Accession Number:** 0001156041
**File Stem:** 0001508592-25-000009
**Filing Date:** 2025-6
**Character Count:** 12990
**Document Hash:** 301f0bbf8b71404743fc895e1339a8f6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001508592-25-000009.hdr.sgml**: 20250617

**ACCESSION NUMBER**: 0001508592-25-000009

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250617

**FILED AS OF DATE**: 20250617

**DATE AS OF CHANGE**: 20250617

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** LONGO PETER F.
- **CENTRAL INDEX KEY:** 0001508592

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-32955
- **FILM NUMBER:** 251054532

**MAIL ADDRESS:**
- **STREET 1:** UNITED TECHNOLOGIES CORPORATION
- **STREET 2:** 10 FARM SPRINGS ROAD
- **CITY:** FARMINGTON
- **STATE:** CT
- **ZIP:** 06032
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HOUSTON AMERICAN ENERGY CORP
- **CENTRAL INDEX KEY:** 0001156041
- **STANDARD INDUSTRIAL CLASSIFICATION:** CRUDE PETROLEUM & NATURAL GAS [1311]
- **ORGANIZATION NAME:** 01 Energy & Transportation
- **EIN:** 760675953
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 801 TRAVIS STREET, SUITE 1425
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77002
- **BUSINESS PHONE:** 7132226966

**MAIL ADDRESS:**
- **STREET 1:** 801 TRAVIS STREET SUITE 1425
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77002

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>LONGO PETER F.<br><sub>(Last) (First) (Middle)</sub><br>C/O HOUSTON AMERICAN ENERGY CORP.<br>801 TRAVIS STREET, SUITE 1425<br><sub>(Street)</sub><br>HOUSTON, TX 77002<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-06-17 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_CEO and President_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>HOUSTON AMERICAN ENERGY CORP [ HUSA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock option (right to buy) | 16.3<sup>(13)</sup> | 2025-01-15 |  | A |  | 920.25<sup>(1)(13)</sup> |  | 2025-07-15<sup>(2)</sup> | 2035-01-15<sup>(2)</sup> | Common Stock | 920.25<sup>(1)(13)</sup> | $0 | 3152.24<sup>(13)</sup> | D |  |
| Stock option (right to buy) | 14.1<sup>(13)</sup> | 2025-02-15 |  | A |  | 1063.83<sup>(3)(13)</sup> |  | 2025-08-15<sup>(4)</sup> | 2035-02-15<sup>(4)</sup> | Common Stock | 1063.83<sup>(3)(13)</sup> | $0 | 4216.07<sup>(13)</sup> | D |  |
| Stock option (right to buy) | 10.7<sup>(13)</sup> | 2025-03-15 |  | A |  | 1401.87<sup>(5)(13)</sup> |  | 2025-09-15<sup>(6)</sup> | 2035-03-15<sup>(6)</sup> | Common Stock | 1401.87<sup>(5)(13)</sup> | $0 | 5617.93<sup>(13)</sup> | D |  |
| Stock option (right to buy) | 5.6<sup>(13)</sup> | 2025-04-15 |  | A |  | 2678.57<sup>(7)(13)</sup> |  | 2025-10-15<sup>(8)</sup> | 2035-04-15<sup>(8)</sup> | Common Stock | 2678.57<sup>(7)(13)</sup> | $0 | 8296.51<sup>(13)</sup> | D |  |
| Stock option (right to buy) | 6.8<sup>(13)</sup> | 2025-05-15 |  | A |  | 2205.88<sup>(9)(13)</sup> |  | 2025-11-15<sup>(10)</sup> | 2035-05-15<sup>(10)</sup> | Common Stock | 2205.88<sup>(9)(13)</sup> | $0 | 10502.39<sup>(13)</sup> | D |  |
| Stock option (right to buy) | $10.6 | 2025-06-17 |  | A |  | 1415.09<sup>(11)</sup> |  | 2025-12-17<sup>(12)</sup> | 2035-06-17<sup>(12)</sup> | Common Stock | 1415.09<sup>(11)</sup> | $0 | 11917.48 | D |  |

---

### Footnotes:

(1) On January 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.63 per share (the trading price for the last business day before the grant date).  Therefore, on January 15, 2025, 9,202.45 options were granted to the reporting person.  Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

(2) The options were granted on January 15, 2025 and are exercisable six months from the date of grant.  The options vest 20% on the date of grant and 80% nine months from the date of grant.

(3) On February 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.41 per share (the trading price for the last business day before the grant date).  Therefore, on February 15, 2025, 10,638.30 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

(4) The options were granted on February 15, 2025 and are exercisable six months from the date of grant.  The options vest 20% on the date of grant and 80% nine months from the date of grant.

(5) On March 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $1.07 per share (the trading price for the last business day before the grant date).  Therefore, on March 15, 2025, 14,018.69 options were granted to the reporting person. Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025. The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table. As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

(6) The options were granted on March 15, 2025 and are exercisable six months from the date of grant. The options vest 20% on the date of grant and 80% nine months from the date of grant.

(7) On April 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.56 per share (the trading price for the last business day before the grant date).  Therefore, on April 15, 2025, 26,785.71 options were granted to the reporting person.  Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025.  The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table.  As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

(8) The options were granted on April 15, 2025 and are exercisable six months from the date of grant.  The options vest 20% on the date of grant and 80% nine months from the date of grant.

(9) On May 15, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $0.68 per share (the trading price for the last business day before the grant date).  Therefore, on May 15, 2025, 22,058.82 options were granted to the reporting person.  Since the date of issue, the Company effected a 10-for-1 reverse stock split which became market effective on June 9, 2025.  The number of options initially issued was 10 times more than the number set forth in the table above and the exercise price was 1/10th of the price set forth in the table.  As a result, the number of shares for which the options are exercisable and the exercise price in the above table have been adjusted to reflect the 10-to-1 reverse stock split.

(10) The options were granted on May 15, 2025 and are exercisable six months from the date of grant.  The options vest 20% on the date of grant and 80% nine months from the date of grant.

(11) On June 17, 2025, the reporting person received a grant of options to acquire a number of shares of the Company's common stock equal to $15,000 divided by the then trading price per share of the Company's common stock, which was $10.60 per share (the trading price for the last business day before the grant date).  Therefore, on June 17, 2025, 1,415.09 options were granted to the reporting person.

(12) The options were granted on June 17, 2025 and are exercisable six months from the date of grant.  The options vest 20% on the date of grant and 80% nine months from the date of grant.

(13) Reflects the 10-for-1 reverse stock split effected by the Company which became market effective on June 9, 2025.

**Signature:** Peter F. Longo  
**Date:** 2025-06-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**